(Q45882698)

English

In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

0 references

1 reference

based on heuristic

inferred from title

author name string

Lucy Deriy

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

Haruko Ogawa

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

Guang-Ping Gao

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

Uri Galili

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

publication date

1 June 2005

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

Cancer Gene Therapy

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

12

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

528-539

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700812

0 references

Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Function and heterogeneity of human Fc receptors for immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Immune complex-mediated antigen presentation induces tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Modulation of the immunological response to hepatitis B virus by antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Elimination of anti-Gal B cells by alpha-Gal ricin1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Induction of complement attack on human cells by Gal(alpha1,3)Gal xenoantigen expression as a gene therapy approach to cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Expression of xenoantigen transformed human cancer cells to be susceptible to antibody-mediated cell killing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Lectin-induced apoptosis of tumour cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Induction of immune tolerance to a transplantation carbohydrate antigen by gene therapy with autologous lymphocytes transduced with adenovirus containing the corresponding glycosyltransferase gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

21 January 2018

MAGE-B5, MAGE-B6, MAGE-C2, andMAGE-C3: four new members of theMAGE family with tumor-specific expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to Hepatitis B Surface Antigen Potentiate the Response of Human T Lymphocyte Clones to the Same Antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of alpha-gal epitopes on HeLa cells transduced with adenovirus containing alpha1,3galactosyltransferase cDNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunochemical studies of the combining sites of the two isolectins, A4 and B4, isolated from Bandeiraea simplicifolia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Decrease of human pancreatic cancer cell tumorigenicity by α1,3galactosyltransferase gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700812

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CGT.7700812

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/15818383

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45882698&oldid=2088345408"